Company
United StatesPublic company, NYSE: MYOMyomo Inc (NYSE: MYO), Boston, MA – FDA Inspections
Inspection records and compliance data for Myomo Inc in Boston, Massachusetts. 2 FDA inspections on record, 1 Form 483, last inspected July 24, 2019. Publicly traded as NYSE: MYO.
Company Profile
This profile covers Myomo Inc based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected July 31, 2012. Last inspected July 24, 2019.
Most cited issue areas
- Lack of or inadequate procedures1 inspection
- Lack of or inadequate process validation1 inspection
- Process changes - review, evaluation and revalidation1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 24, 2019 | Not classified | Medical Devices & Rad Health | 1135844 |
| July 31, 2012 | VAI | Medical Devices & Rad Health · Compliance: Devices | 792698 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Myomo Inc
Stock ticker
MYO
Exchange
NYSE
Share price
$1.19
Market cap
$46.9M
Price as of
November 6, 2026
FEI Number
3006240003
Address
137 Portland St Fl 4, Boston, Massachusetts 02114, United States
Country
United States
ID: e3e243bd-7323-425b-aa31-d2b2adfaa2e5